Cargando…

Elucidating the structural basis for differing enzyme inhibitor potency by cryo-EM

Histidine biosynthesis is an essential process in plants and microorganisms, making it an attractive target for the development of herbicides and antibacterial agents. Imidazoleglycerol-phosphate dehydratase (IGPD), a key enzyme within this pathway, has been biochemically characterized in both Sacch...

Descripción completa

Detalles Bibliográficos
Autores principales: Rawson, Shaun, Bisson, Claudine, Hurdiss, Daniel L., Fazal, Asif, McPhillie, Martin J., Sedelnikova, Svetlana E., Baker, Patrick J., Rice, David W., Muench, Stephen P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828572/
https://www.ncbi.nlm.nih.gov/pubmed/29434040
http://dx.doi.org/10.1073/pnas.1708839115
_version_ 1783302670647296000
author Rawson, Shaun
Bisson, Claudine
Hurdiss, Daniel L.
Fazal, Asif
McPhillie, Martin J.
Sedelnikova, Svetlana E.
Baker, Patrick J.
Rice, David W.
Muench, Stephen P.
author_facet Rawson, Shaun
Bisson, Claudine
Hurdiss, Daniel L.
Fazal, Asif
McPhillie, Martin J.
Sedelnikova, Svetlana E.
Baker, Patrick J.
Rice, David W.
Muench, Stephen P.
author_sort Rawson, Shaun
collection PubMed
description Histidine biosynthesis is an essential process in plants and microorganisms, making it an attractive target for the development of herbicides and antibacterial agents. Imidazoleglycerol-phosphate dehydratase (IGPD), a key enzyme within this pathway, has been biochemically characterized in both Saccharomyces cerevisiae (Sc_IGPD) and Arabidopsis thaliana (At_IGPD). The plant enzyme, having been the focus of in-depth structural analysis as part of an inhibitor development program, has revealed details about the reaction mechanism of IGPD, whereas the yeast enzyme has proven intractable to crystallography studies. The structure–activity relationship of potent triazole-phosphonate inhibitors of IGPD has been determined in both homologs, revealing that the lead inhibitor (C348) is an order of magnitude more potent against Sc_IGPD than At_IGPD; however, the molecular basis of this difference has not been established. Here we have used single-particle electron microscopy (EM) to study structural differences between the At and Sc_IGPD homologs, which could influence the difference in inhibitor potency. The resulting EM maps at ∼3 Å are sufficient to de novo build the protein structure and identify the inhibitor binding site, which has been validated against the crystal structure of the At_IGPD/C348 complex. The structure of Sc_IGPD reveals that a 24-amino acid insertion forms an extended loop region on the enzyme surface that lies adjacent to the active site, forming interactions with the substrate/inhibitor binding loop that may influence inhibitor potency. Overall, this study provides insights into the IGPD family and demonstrates the power of using an EM approach to study inhibitor binding.
format Online
Article
Text
id pubmed-5828572
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher National Academy of Sciences
record_format MEDLINE/PubMed
spelling pubmed-58285722018-02-28 Elucidating the structural basis for differing enzyme inhibitor potency by cryo-EM Rawson, Shaun Bisson, Claudine Hurdiss, Daniel L. Fazal, Asif McPhillie, Martin J. Sedelnikova, Svetlana E. Baker, Patrick J. Rice, David W. Muench, Stephen P. Proc Natl Acad Sci U S A Biological Sciences Histidine biosynthesis is an essential process in plants and microorganisms, making it an attractive target for the development of herbicides and antibacterial agents. Imidazoleglycerol-phosphate dehydratase (IGPD), a key enzyme within this pathway, has been biochemically characterized in both Saccharomyces cerevisiae (Sc_IGPD) and Arabidopsis thaliana (At_IGPD). The plant enzyme, having been the focus of in-depth structural analysis as part of an inhibitor development program, has revealed details about the reaction mechanism of IGPD, whereas the yeast enzyme has proven intractable to crystallography studies. The structure–activity relationship of potent triazole-phosphonate inhibitors of IGPD has been determined in both homologs, revealing that the lead inhibitor (C348) is an order of magnitude more potent against Sc_IGPD than At_IGPD; however, the molecular basis of this difference has not been established. Here we have used single-particle electron microscopy (EM) to study structural differences between the At and Sc_IGPD homologs, which could influence the difference in inhibitor potency. The resulting EM maps at ∼3 Å are sufficient to de novo build the protein structure and identify the inhibitor binding site, which has been validated against the crystal structure of the At_IGPD/C348 complex. The structure of Sc_IGPD reveals that a 24-amino acid insertion forms an extended loop region on the enzyme surface that lies adjacent to the active site, forming interactions with the substrate/inhibitor binding loop that may influence inhibitor potency. Overall, this study provides insights into the IGPD family and demonstrates the power of using an EM approach to study inhibitor binding. National Academy of Sciences 2018-02-20 2018-02-06 /pmc/articles/PMC5828572/ /pubmed/29434040 http://dx.doi.org/10.1073/pnas.1708839115 Text en Copyright © 2018 the Author(s). Published by PNAS. https://creativecommons.org/licenses/by-nc-nd/4.0/ This open access article is distributed under Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Biological Sciences
Rawson, Shaun
Bisson, Claudine
Hurdiss, Daniel L.
Fazal, Asif
McPhillie, Martin J.
Sedelnikova, Svetlana E.
Baker, Patrick J.
Rice, David W.
Muench, Stephen P.
Elucidating the structural basis for differing enzyme inhibitor potency by cryo-EM
title Elucidating the structural basis for differing enzyme inhibitor potency by cryo-EM
title_full Elucidating the structural basis for differing enzyme inhibitor potency by cryo-EM
title_fullStr Elucidating the structural basis for differing enzyme inhibitor potency by cryo-EM
title_full_unstemmed Elucidating the structural basis for differing enzyme inhibitor potency by cryo-EM
title_short Elucidating the structural basis for differing enzyme inhibitor potency by cryo-EM
title_sort elucidating the structural basis for differing enzyme inhibitor potency by cryo-em
topic Biological Sciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828572/
https://www.ncbi.nlm.nih.gov/pubmed/29434040
http://dx.doi.org/10.1073/pnas.1708839115
work_keys_str_mv AT rawsonshaun elucidatingthestructuralbasisfordifferingenzymeinhibitorpotencybycryoem
AT bissonclaudine elucidatingthestructuralbasisfordifferingenzymeinhibitorpotencybycryoem
AT hurdissdaniell elucidatingthestructuralbasisfordifferingenzymeinhibitorpotencybycryoem
AT fazalasif elucidatingthestructuralbasisfordifferingenzymeinhibitorpotencybycryoem
AT mcphilliemartinj elucidatingthestructuralbasisfordifferingenzymeinhibitorpotencybycryoem
AT sedelnikovasvetlanae elucidatingthestructuralbasisfordifferingenzymeinhibitorpotencybycryoem
AT bakerpatrickj elucidatingthestructuralbasisfordifferingenzymeinhibitorpotencybycryoem
AT ricedavidw elucidatingthestructuralbasisfordifferingenzymeinhibitorpotencybycryoem
AT muenchstephenp elucidatingthestructuralbasisfordifferingenzymeinhibitorpotencybycryoem